早发中暑相关急性肝损伤的临床特征及危险因素分析
该研究回顾性分析了2015年6月至2022年8月海安市人民医院重症医学科收治的76例中暑患者的临床资料,按入院24小时内是否发生急性肝损伤分为早发肝损伤组与早发非肝损伤组。结果显示早发肝损伤发生率为60.53%(46例),以转氨酶与总胆红素同时升高为主(50.00%),转氨酶升高者中轻度占64.87%。早发肝损伤组APACHE II、SOFA、乳酸、IL-6、PCT、ALT、AST、TBil、γ-GGT、LDH、CK、CK-MB、cTnI、MYO、NT-proBNP、PT、APTT、D-二聚体均显著升高,PLT显著降低,28天死亡率显著升高。多因素Logistic回归提示PLT、IL-6、LDH为独立危险因素,IL-6预测价值最高。
要点
- 76例中暑患者中46例(60.53%)在入院24小时内发生急性肝损伤,28天死亡率早发肝损伤组28.26%(13/46)vs 早发非肝损伤组6.67%(2/30),差异有统计学意义(P<0.05)。
- 早发肝损伤以转氨酶与TBil同时升高为主(23/46,50.00%),单纯转氨酶升高14例(30.43%),单纯TBil升高9例(19.57%);转氨酶升高者中轻度24例(64.87%)、中度5例(13.51%)、重度8例(21.62%)。
- 多因素Logistic回归显示PLT(OR 0.986,95%CI 0.974-0.998)、IL-6(OR 1.027,95%CI 1.012-1.041)、LDH(OR 1.002,95%CI 1.000-1.004)为早发中暑相关急性肝损伤的独立危险因素(均P<0.05)。
- IL-6预测早发肝损伤的AUC为0.897(95%CI 0.824-0.971),最佳阈值为48.25 ng/L时敏感度95.7%、特异度73.3%,预测价值最高;LDH的AUC为0.833(95%CI 0.739-0.927),PLT的AUC为0.672(95%CI 0.548-0.797),预测价值最低。
适用人群与场景
- 2015年6月至2022年8月海安市人民医院重症医学科收治的中暑患者76例。
- 按入院24小时内是否发生急性肝损伤分为早发肝损伤组与早发非肝损伤组。
诊断标准与关键阈值
- 早发中暑相关急性肝损伤定义为入院24小时内发生急性肝损伤。
- IL-6预测早发中暑相关急性肝损伤的最佳诊断阈值为48.25 ng/L,敏感度95.7%,特异度73.3%。
红旗征与不能漏的情况
- 早发肝损伤组28天死亡率28.26%(13/46),显著高于早发非肝损伤组的6.67%(2/30)(P<0.05)。
- 入院24小时内PLT显著降低、IL-6、LDH、APACHE II、SOFA、乳酸、PCT、PT、APTT、D-二聚体、CK、CK-MB、cTnI、MYO、NT-proBNP显著升高提示早发肝损伤风险。
研究设计与关键结果
- 研究为回顾性分析,共纳入76例中暑患者,46例(60.53%)发生早发急性肝损伤。
- 早发肝损伤组14例(30.43%)单纯转氨酶升高、9例(19.57%)单纯TBil升高、23例(50.00%)转氨酶与TBil同时升高;转氨酶升高者中轻度24例(64.87%)、中度5例(13.51%)、重度8例(21.62%)。
- 与早发非肝损伤组相比,早发肝损伤组入院24小时内APACHE II、SOFA、乳酸、IL-6、PCT、ALT、AST、TBil、γ-GGT、LDH、CK、CK-MB、cTnI、MYO、NT-proBNP、PT、APTT、D-二聚体均显著升高,PLT显著降低,28天死亡率显著升高[28.26%(13/46)vs 6.67%(2/30)],差异均有统计学意义(均P<0.05)。
- 单因素Logistic回归显示APACHE II评分、SOFA评分、PLT、乳酸、IL-6、PCT、γ-GGT、LDH、CK、CK-MB、cTnI、MYO、PT、APTT、D-二聚体均为早发中暑相关急性肝损伤的危险因素(均P<0.05)。
- 多因素Logistic回归显示PLT、IL-6、LDH为独立危险因素,OR(95%CI)分别为0.986(0.974-0.998)、1.027(1.012-1.041)、1.002(1.000-1.004),均P<0.05。
- ROC曲线分析显示PLT、IL-6、LDH预测早发肝损伤的AUC分别为0.672(95%CI 0.548-0.797)、0.897(95%CI 0.824-0.971)、0.833(95%CI 0.739-0.927),IL-6预测价值最高,PLT预测价值最低。
证据类型、等级与局限
- 证据类型:回顾性临床分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对中暑患者入院24小时内应关注PLT、IL-6、LDH及肝功能指标,以早期识别早发急性肝损伤。
- IL-6在48.25 ng/L时对早发中暑相关急性肝损伤具有较高预测价值(敏感度95.7%,特异度73.3%),作者认为可用于早期识别。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the clinical characteristics and risk factors of early acute liver injury in patients with heat stroke (HS), and to provide basis for early identification of HS-related liver injury and its pathogenesis in clinical practice.
METHODS: The clinical data of patients with HS admitted to the department of critical care medicine of Haian People's Hospital from June 2015 to August 2022 were retrospectively analyzed. The patients with HS were divided into early liver injury group and early non-liver injury group according to the occurrence of acute liver injury within 24 hours of admission. The differences of basic data, clinical data, laboratory indexes and clinical outcomes of the two groups were analyzed. Logistic regression was used to analyze the risk factors for early HS-related acute liver injury, and receiver operator characteristic (ROC) curves were drawn to evaluate their value in predicting the occurrence of early HS-related acute liver injury.
RESULTS: A total of 76 patients with HS were enrolled, and 46 patients with acute liver injury, accounting for 60.53%. In the early liver injury group, 14 patients (30.43%) had elevated aminotransferase alone, 9 patients (19.57%) had elevated total bilirubin (TBil) alone, and 23 patients (50.00%) had elevated both aminotransferase and TBil. Among the patients with elevated aminotransferases, 24 patients (64.87%) had mild elevation, 5 patients (13.51%) had moderate elevation, 8 patients (21.62%) had severe elevation. Compared with the early non-liver injury group, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), arterial blood lactate (Lac), interleukin-6 (IL-6), procalcitonin (PCT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), TBil, γ-gamma glutamyl transferase (γ-GGT), lactate dehydrogenase (LDH), creatine kinase (CK), MB isoenzyme of creatine kinase (CK-MB), cardiac troponin I (cTnI), myoglobin (MYO), N-terminal B-type pro-brain natriuretic peptide (NT-proBNP), prothrombin time (PT), activated partial thromboplastin time (APTT), D-dimer in the early liver injury group were significantly increased, while platelet count (PLT) were significantly decreased within 24 hours after admission, the 28-day mortality was significantly increased [28.26% (13/46) vs. 6.67% (2/30)], and the differences were statistically significant (all P < 0.05). Univariate Logistic regression analysis showed that APACHE II score, SOFA score, PLT, Lac, IL-6, PCT, γ-GGT, LDH, CK, CK-MB, cTnI, MYO, PT, APTT, D-dimer were risk factors of early HS-related acute liver injury (all P < 0.05). Multivariate Logistic regression analysis showed that PLT, IL-6, and LDH were independent risk factors of early HS-related acute liver injury [odds ratio (OR) and 95% confidence interval (95%CI) were 0.986 (0.974-0.998), 1.027 (1.012-1.041), and 1.002 (1.000-1.004), all P < 0.05]. The ROC curve analysis showed that the area under the ROC curve (AUC) of PLT, IL-6 and LDH for predicting the occurrence of early HS-related acute liver injury was 0.672 (95%CI was 0.548-0.797), 0.897 (95%CI was 0.824-0.971) and 0.833 (95%CI was 0.739-0.927), respectively. IL-6 had the highest predictive value for early HS-related liver injury. When the optimal diagnostic threshold of IL-6 was 48.25 ng/L, the sensitivity was 95.7%, the specificity was 73.3%, and the predictive value of PLT was the lowest.
CONCLUSIONS: The early HS-related liver injury is mainly manifested as the simultaneous elevation of aminotransferase and TBil, and most of cases are mild liver injury. PLT, IL-6 and LDH are independent risk factors of early HS-related acute liver injury.
参考来源
- Liu A, Pu Z, Chu L, et al. [Analysis of clinical characteristics and risk factors of early heat stroke-related acute liver injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37545450. doi:10.3760/cma.j.cn121430-20230301-00128
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。